Please login to the form below

Not currently logged in
Email:
Password:

company strategy

This page shows the latest company strategy news and features for those working in and with pharma, biotech and healthcare.

FDA turns down Celgene’s filing for multiple sclerosis drug

FDA turns down Celgene’s filing for multiple sclerosis drug

chief executive Mark Alles on a conference call yesterday evening when he said the drug is an important part of the company’s “diversification and growth strategy”. ... The company said on the call they did not think the FDA’s position related to

Latest news

  • CDC backs GSK’s Shingrix over Merck & Co’s Zostavax CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

    approved in the US earlier this month and is a key component of the company’s commercial strategy in the next few years with sales expected to exceed £1bn (around ... the company took a dive.

  • Novartis looks outside pharma for digital transformation Novartis looks outside pharma for digital transformation

    Bodson will join the Swiss pharma firm in January, when he will be responsible for creating and executing a company-wide digital strategy. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

  • Vas Narasimhan takes top Novartis job on Jimenez departure Vas Narasimhan takes top Novartis job on Jimenez departure

    the company has a strong pipeline that has benefitted from a tighter focus. ... Harvard -trained physician Narasimhan has been with Novartis since 2005 and has held a number of roles at the company across commercial, drug development and strategy but is

  • Stada's €4.1bn takeover goes through Stada's €4.1bn takeover goes through

    Stada's 4.1bn takeover goes through. German pharma company finally comes under new ownership. ... The company's revised strategy will focus on improving efficiencies in its business - in particular reducing the cost of sales - and accelerating the launch

  • Top tips for “digitally cautious” pharma Top tips for “digitally cautious” pharma

    Take a collaborative approach to defining and delivering an effective strategy, both within the company and with outside stakeholders. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

More from news
Approximately 52 fully matching, plus 137 partially matching documents found.

Latest Intelligence

  • Accelerating innovation Accelerating innovation

    Research strategy. Alexandre has been with the company for five years, having previously held clinical development and medical affairs leadership roles with the likes of Sanofi and Novartis. ... Since he joined the French biopharmaceutical company he has

  • Patently unclear? Patently unclear?

    is vital to the long-term success of the company and, in the shorter term, having assets to showcase to potential investors. ... Clearly if useful patent protection is to be obtained in a biotech company’s target markets, the patenting strategy must

  • Tools for the digital world Tools for the digital world

    The company behind this ‘smart pill’technology, Proteus Digital Health, believes that patients will become more engaged and therefore more adherent to their therapies - leading to better health outcomes. ... Samuel Pygall, pharmacy strategy lead for

  • Embracing multi-channel in the digital age Embracing multi-channel in the digital age

    preferences, over and above a company’s digital strategy. ... It’s this sustainable method that will ensure a bright future for any company that embraces change.

  • The EarthWorks: New ways to improve patient care The EarthWorks: New ways to improve patient care

    It is also essential that they are built in collaboration with clinical, academic and patient expertise, as well as with the pharmaceutical company. ... What I am saying is that whatever way we want to define 'marketing', the goal of building true

More from intelligence
Approximately 4 fully matching, plus 30 partially matching documents found.

Latest appointments

  • Nabriva Therapeutics appoints chief medical officer Nabriva Therapeutics appoints chief medical officer

    Nabriva Therapeutics appoints chief medical officer. Jennifer Schranz will lead the company’s clinical development business. ... Dr Schran’z new role will see her lead clinical development and medical affairs, contributing to the company’s business

  • Alexion Pharmaceuticals adds to its board Alexion Pharmaceuticals adds to its board

    Reinsdorf joins at a time when the company aims to “strengthen its leadership position in rare diseases”. ... She said: “I am excited to join Alexion’s board of directors at a pivotal time for the company as it executes its strategy to deliver

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    US biopharmaceutical company Acadia Pharmaceuticals has appointed Damien McDevitt (pictured) as senior vice president of corporate development. ... The company’s former SVP, strategy and business development Bob Mischler will assume responsibilities

  • ThromboGenics bolsters leadership team ThromboGenics bolsters leadership team

    Vangeersdaele will be leading and developing the overall commercial strategy for the company’s recently formed Jetrea business unit, which was created following ThromboGenics regaining full rights to Jetrea from Novartis. ... Patrik De Haes, chief

  • Apeiron bolsters management board Apeiron bolsters management board

    During the course of his career, Llewellyn-Davies supported Medigene’s strategy to form an immunotherapy company and he assisted in initial public offerings for Wilex. ... support our growth strategy.

More from appointments
Approximately 0 fully matching, plus 56 partially matching documents found.

Latest from PMHub

  • From ideals to execution – exploring the realities of patient-centricity

    We ran a 2-week online expert panel earlier this year, inviting our panel to discuss, as openly as possible, their company vision, the strategy and structure that they were putting

  • 5 steps to a smart key opinion leader (KOL) strategy

    5 steps to a smart key opinion leader (KOL) strategy. For a pharmaceutical company, the backing of a key opinion leader (KOL) is essential to give their products any kind of ... You may choose to focus more on certain elements than others, but here are 5

  • Delivering a better eDetail: Strategy-led user-centred methodology in practice

    customer and company alike, if strategy underpins every decision made. ... Alignment with overarching brand and/or campaign strategy: how does this eDetail fit within the many other touchpoints the customer has with our brand?

  • Healthcare in the Digital Age

    also global director customer insights and strategy at medical device company Thermo Fisher Scientific.“ Over the last ten years, pharmaceutical companies have become more selective, and did more and more segmentation

  • IMARC Group

    IMARC Group. IMARC is a leading market research company that offers management strategy and market research worldwide. ... This is a FREE listing. Company Details.

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics